539 results on '"Gringeri, E"'
Search Results
102. Microwave ablation for breast cancer liver metastasis
103. Laparoscopic liver resection versus transarterial chemoembolization for hepatocellular carcinoma in child B cirrhosis: a propensity score analysis
104. Video-laparoscopic MW ablation in a European high volume center: safety and efficacy of 970 procedures
105. Liver resection for hilar cholangiocarcinoma in patients over 70 years: does preoperative cholangitis exclude older patients from surgery?
106. Advanced intrahepatic cholangiocarcinoma (iCCA) treated with arterial-directed therapies (ADT): Outcomes and safety from a multicenter Italian experience
107. Prognostic meaning of BAP1 and PBRM1 expression in intrahepatic cholangiocarcinoma
108. Serum and bile squamous cell carcinoma antigen detection: A new prognostic marker in patients with perihilar cholangiocarcinoma
109. Prognostic role of BAP1 and PBRM1 expression in intrahepatic cholangiocarcinoma
110. Video-laparoscopic MW ablation in a European high volume center: Safety and efficacy of 891 procedures
111. Safety and efficacy of ALPPS for intrahepatic cholangiocarcinoma in 102 patients: A multi-center study
112. SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT)
113. Representing Subnormothermic Machine Perfusion in Fatty Livers: The Complete Picture?
114. OC.13.1: Eradication of HCV in Patients Awaiting Liver Transplantation does not Increase Drop-Out Due to HCC Progression
115. Worse Graft Survival in HCV-Infected Transplanted Females Receiving a Male Donor Graft. The Liver Match Study
116. Worse Graft Survival in HCV-Infected Transplanted Females Receiving a Male Donor Graft. The Liver Match Study
117. Pediatric liver transplantation: The University of Padua experience
118. E' POSSIBILE RAZIONALIZZARE I CONSUMI DI ALBUMINA PER PAZIENTE CIRROTICO?
119. Laparoscopic ablation for HCC: proposal of a 6-months mortality score for patient selection based on more than 1000 procedures
120. Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression
121. The survival benefit of laparoscopic ablation over trans-arterial chemoembolization in patients with hepatocellular carcinoma ineligible for liver resection or percutaneous ablation
122. Local prothrombotic state in portal venous system in cirrhosis
123. Laparoscopic ablation for hepatocellular carcinoma: proposal of a 6-months mortality score for patient selection based on more than 1000 procedures
124. Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation
125. HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience
126. QT interval measurement and myocardial perfusion scintigrafy to assess cardiac funcion in patients with cirrhosis before liver transplantation
127. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial
128. 764P - Advanced intrahepatic cholangiocarcinoma (iCCA) treated with arterial-directed therapies (ADT): Outcomes and safety from a multicenter Italian experience
129. Graft survival is worse in HCV positive females transplanted with male donor grafts
130. QT interval measurement and myocardial perfusion scintigrafy to assess cardiac funcion in patients with cirrhosis before liver transplantation
131. OC.03.9 SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT)
132. Peripheral NK cells in patients with HCV recurrence after liver transplantation during interferon-free antiviral therapy
133. P.10.8 PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
134. Laparoscopic ablation and salvage transplantation for patients with hepatocellular carcinoma
135. Salvage liver transplantation after laparoscopic resection for hepatocellular carcinoma: a multicenter experience
136. PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
137. Pathogenesis and clinical impact of relative adrenal insufficiency in hospitalized patients with acute decompensation of cirrhosis
138. A Bayesan methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
139. Safety and Efficacy of Transcatheter Arterial Chemoembolization (Tace) in Unresectable Biliary Cancer
140. SAT-269 - Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation
141. THU-071 - Laparoscopic ablation for hepatocellular carcinoma: proposal of a 6-months mortality score for patient selection based on more than 1000 procedures
142. SCLEROSING CHOLANGITIS AND PULMONARY HISTIOCYTOSIS X TREATED BY LIVER TRANSPLANTATION
143. CISTI VERA SOLITARIA DEL PANCREAS NEGLI ADULTI: UNA DIFFICILE DIAGNOSI DIFFERENZIALE
144. IL TRAPIANTO DI FEGATO COME SOLUZIONE TERAPEUTICA PER L'EPATOCARCINOMA AVANZATO SU CIRROSI
145. LIVER TRANSPLANTATION AND ASPERGILLUS FUMIGATUS INFECTION: A FAVORABLE OUTCOME CASE
146. I PRIMI 5 CASI DI TRAPIANTO DI FEGATO DA DONATORE VIVENTE NELL'ESPERIENZA DI PADOVA
147. CONVERSIONE CICLOSPORINA VS TACROLIMUS NELLA GESTIONE DELLA TERAPIA IMMUNOSOPPRESSIVA POST-OLTX: ESPERIENZA DI CENTRO
148. THERAPEUTIC OPTIONS FOR HEPATIC TRAUMA: FROM NON OPERATIVE TREATMENT TO LIVER TRANSPLANTA
149. RADIOFREQUENCY ABLATION SYSTEM: A NEW TOOL CHANGING THE THERAPEUTIC STRATEGIES OF SMALL NODULARITIES OF THE LIVER
150. Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A case match analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.